Send Orders for Reprints to reprints@benthamscience.ae Current Pharmaceutical Design, 2016, 22, 000-000 Nanoparticulate Drug Delivery to Colorectal Cancer: Formulation Strategies and Surface Engineering Thao Truong-Dinh Tran1,3, Phuong Ha-Lien Tran2, Yichao Wang4, Puwang Li1 and Lingxue Kong1,* Institute for Frontier Materials, Deakin University, Waurn Ponds, Victoria 3216, Australia; 2School of Medicine, Deakin University, Waurn Ponds, Victoria 3216, Australia; 3Pharmaceutical Engineering Laboratory, Biomedical Engineering Department, International University, Vietnam National University – Ho Chi Minh City, Vietnam; School of Electrical and Computer Engineering, RMIT University, Melbourne, Australia Abstract: The evolution of polymer-based nanoparticle as a drug delivery carrier has greatly contributed to the development of advanced nano and micro-medicine in the past few decades The polymer-based nanoparticles of biodegradable and biocompatible polymers such as poly (lactide-co-glycolide) and chitosan which have been approved by Food & Drug Administration and/or European Medicine Agency can particularly facilitate the maintaining of specific properties for a real transition from laboratory to the clinical oral and parental administration This review presents an overview of the strategies of preparing polymeric nanoparticles and using them for targeting colorectal cancer Theranostics and surface engineering aspects of nanoparticle design in colonic cancer delivery are also highlighted Lingxue Kong Keywords: Nanoparticles, poly (lactide-co-glycolide), chitosan, colorectal cancer, theranostic, surface engineering INTRODUCTION Colorectal cancer is one of the major universal public health problems and causes of death worldwide [1, 2] A major draw-back of conventional formulations for colorectal cancer is their side effects and toxicity caused by the distribution of drug around the body due to its design in systematic delivery therapeutics [3, 4] In other words, these approaches to colorectal cancer treatment are nonspecific One of other major limitations of some promising anticancer drugs such as docetaxel and paclitaxel is the insolubility property in water and therefore, leading to the poor absorption and bioavailability of these drugs [5, 6] Targeted drug delivery, therefore, is one of indispensable strategies against this type of cancers by state-of-the-art techniques of controlled solid dosage forms or micro/nanoparticles to improve solubility and bioavailability, and enhance drug distribution to the target organ The delivery would also improve the stability of model drugs while also reducing systemic side-effects [7-9] Potential applications of nanoparticles have been demonstrated by 40 nanomedicine products that have been approved for clinical use in the past two decades [10] Polymer-based nanoparticles have received particular attentions in design and fabrication of targeted drug delivery systems recently Overall, it is evident that polymer-based nanoparticles could contribute to a promising tumor-targeted drug delivery system with great potential in colorectal cancer therapy The shortcoming of these potential approaches, however, should also be evaluated carefully Information on the development of current strategies for targeted colorectal cancer summarized in this review would give the readers a general but deep understanding of practical approaches and effective carriers that can be applied in targeted colorectal cancer delivery (Fig 1) Most of colorectal cancer survivals depend on how early the stage at diagnosis is [11] Overcoming the lack of sensitive property of current devices and the nature of small colorectal neoplasia of the disease which hinder a successful treatment, a tool for observation and diagnosis of precancerous lesions would be a great *Address correspondence to this author at Institute for Frontier Materials, Deakin University, Waurn Ponds, Victoria, 3217, Australia; Tel/Fax: +61352272087, ++61352271002; E-mails: lingxue.kong@deakin.edu.au 1381-6128/16 $58.00+.00 contribution to the field Here the imaging agents encapsulated in polymer-based nanoparticles are the subjects of the discussion Furthermore, efficient delivery of the nanoparticles with surface engineering are also outlined CURRENT POLYMER STRATEGIES DEVELOPED FOR TARGETED COLORECTAL CANCER 2.1 Poly (Lactide-co-Glycolide) (PLGA)-Based Approaches Since its discovery in the 1970, PLGA has become one of the most common and feasible polymers developed for controlled drug delivery among polymeric nanoparticles [12-16] It has been approved by the U.S Food and Drug Administration as a material for use in medical applications and since then a number of drugs have been investigated to incorporate in PLGA encompassing laboratory products and commercial products with FDA approval [17-27] Typical structure of PLGA has been known as the hydrophobic synthetic and linear copolymer constructed by two different types of monomer which are glycolic acid and lactic acid [28-31] The molar ratio of these monomers and molecular weight defines the commercial form of PLGA and its physicochemical properties (Fig 2) [32-34] The crystal degree of PLGA depends on molecular weight and this molar ratio (higher 70% glycolic indicates amorphous state in nature) [35] The increase of the glycolic content in the ratio can result in less hydrophobic character and lower required degradation time of PLGA [36, 37] In the presence of water, these monomers will be released and then subjected to metabolism via the Krebs cycle easily [38], resulting in a minimal systemic toxicity associated with biocompatible and biodegradable properties of PLGA for controlled drug delivery [39-41] Therefore, PLGA has attracted many attentions and commonly used as a potential carrier for the encapsulation of anti-cancer drugs In addition, other specific characteristics of PLGA such as drug degradation protection, sustained drug release, possibility of surface engineering to modify surface properties and targeted drug delivery make it become more promising in further applications [8, 12] Despite the widespread application of PLGA and different methods that have been used in designing nanoparticles for drug delivery, there have been few reports describing PLGA-based nanoparticles for targeted drug delivery to colorectal cancer © 2016 Bentham Science Publishers Current Pharmaceutical Design, 2016, Vol 22, No 00 Tran et al Fig (1) Current strategies of polymer-based nanoparticles for targeted colorectal cancer O O HO H O n m O Fig (2) Typical structure of a PLGA n= number of units of lactic acid; m= number of units of glycolic acid For example, PLGA 50:50 identifies 50% lactic acid and 50% glycolic acid 2.1.1 Emulsion Solvent Evaporation PLGA-based nanoparticles have received tremendous attention as a powerful drug delivery system for cancer-related diseases Among various fabrication methods, the emulsion solvent evaporation has been commonly reported as a potential technique for targeted colorectal cancer In the method developed by Wang et al., [43], dichloromethane was used as organic solvent to dissolve PLGA and paclitaxel – a poorly water-soluble drug The O/W (oilin-water) emulsion was formed by adding organic phase to aqueous phase containing polyvinyl alcohol (PVA) Meanwhile, the particle size was controlled by probe sonication This kind of technique is quite simple and only allows the encapsulation of hydrophobic drugs Alternatively, the double emulsion solvent evaporation method was developed to encapsulate hydrophilic drugs instead of hydrophobic drugs In previous research of targeted colorectal cancer of 5-fluorouracil [42, 44, 45], while drug was dissolved in water to obtain an inner aqueous phase, PLGA was dissolved in an organic solvent The aqueous drug solution (W) was emulsified in the organic phase with a probe sonicator to form W/O (water-in-oil) emulsion which was then emulsified in PVA solution, resulting in W/O/W emulsion Similarly, Sureban et al [46] have utilized this technique to encapsulate DCAMKL-1 specific siRNA in PLGA nanoparticles They demonstrated that an inhibition of colorectal cancer tumor growth could be achieved by targeting DCAMKL-1 Detailed illustration of this method is shown in Fig (3) 2.1.2 Combination of Salting-Out and Emulsion Evaporation This modification method was developed using water-miscible solvents and salting-out agents in the process of emulsion evaporation method For example, to explore the inhibition of adenocarcinoma cells (HT-29) using meloxicam in PLGA nanoparticles, acetone (AC) was mixed with dichloromethane to dissolve PLGA and the model drug before pouring the mixture into an aqueous solution containing salting-out agent [47] AC was used as a water-miscible solvent to induce the formation of PLGA nanoparticles through the diffusion of AC into the aqueous phase [48-59] In addition to AC, MgCl2 was used as a salting-out agent which could cause the salting-out effect by a sudden change in the salt concentration in the continuous phase of the emulsion under the dilution process [57, 59-61] Consequently, a stable O/W emulsion was expected to be obtained due to the prevention of phenomena commonly observed when an organic solvent is mixed with water [62] The most frequently used salting-out agents are MgCl2, magnesium acetate, NaCl Nanoparticulate Drug Delivery to Colorectal Cancer Current Pharmaceutical Design, 2016, Vol 22, No 00 Probe sonicator Probe sonicator Drug PVA solution Fig (3) Illustration of double emulsion solvent evaporation [42] and CaCl2 [62, 63] Although this method can be useful for encapsulation of heat sensitive drugs and proteins that are agents introduced in a process without temperature and with minimizing tension to protein encapsulants, respectively, the main disadvantage of this method is the requirement of severe purification [8, 64, 65] 2.1.3 Nanoprecipitation Usually, the nanoprecipitation method has been developed by dropwising a polymer in an organic solvent into an aqueous phase (anti-solvent) [66-69] It is also called the solvent displacement method with one-step process In the effort of functionalizing aptamer on PLGA containing curcumin nanoparticles as delivery system to colorectal cancer cells [70], acetonitrile, an organic solution containing PLGA and curcumin, was added in the lipid aqueous phase containing lecithin and Pegylated phospholipid (DSPEPEG2000-COOH) for self-assembled formation of nanoparticles Ethanol, methanol and AC instead of acetonitrile could be considered as alternative solvents of polymers in the nanoprecipitaion method In addition, a surfactant could be added in the aqueous phase for stabilization OH OH OH HO O HO NH2 O HO O NH2 O HO n O OH NH2 Fig (4) Chemical structure of chitosan 2.2 Chitosan (CS)-Based Systems There has been a wide trend of using CS in drug delivery systems recently, especially for gastrointestinal delivery due to exhibition of good mucoadhesive features, prolonged residence time in the intestine and, subsequently, enhancing the bioavailability of the drugs [71-76] Furthermore, it is a nontoxic and biocompatible polysaccharide [77-80] With regards to a specific structure of a weak base having pKa value of about 6.2 - 7.0 (Fig 4), pure CS can be easily dissolved in an acidic environment with pH in the range within stomach due to the protonation of amino groups [81-83] CS, therefore, usually needs a modification or nanoparticulate formulation in targeting oral delivery for colorectal cancer in spite of the well-known advantage of chitosan that can release therapeutic agents specifically at the colon by colonic microflora (glycosidic linkages degradation) [84-86] 2.2.1 Ionic Gelation In this method, the electrostatic interaction between positive charged CS solution and negative charged salt solution was used in preparation of CS nanoparticles [87-89] According to Li et al [90] and Jain et al [91, 92], this method was successfully applied in preparation of CS nanoparticles for delivery of 5-fluorouracil and oxaliplatin in colorectal cancer therapy using sodium tripolyphosphate solution as the negative charged solution Furthermore, the loading combination of 5-fluorouracil and leucovorin in CS nanoparticles by this method has resulted in a promising and effective multiple anticancer drugs delivery system in the chemotherapy of colorectal cancer [93] In addition to the therapeutic purpose in colonic delivery, another research used CS to develop a safe livertargeting cytokine delivery system that exploited liver immunity to prevent colorectal liver metastasis [94] Using similar ionic gelation method, Xu et al [94] demonstrated that the system where interluekin-12 encapsulated in CS nanoparticles could trigger antitumor immunity in the liver by the interleukin-12 accumulation Fig (5) briefly illustrates the ionic gelation method in which CS was firstly dissolved in an aqueous solution and then, a solution of negatively charged drug(s) was dropped into CS solution under magnetic stirring at room temperature for the formation of CS nanoparticles The greatest advantage of this method is its simplicity and mild generation which would be applied to most CS nanoparticle preparation processes for colorectal cancer delivery [95-97] 2.2.2 Nanogels More recently, a modified ionic gelation method has been developed to prepare the chitosan-based nanogels According to studies of Feng et al [98, 99] with the purpose of improving oral bioavailability of doxorubicin and mucoadhesive properties, Current Pharmaceutical Design, 2016, Vol 22, No 00 Tran et al in the aqueous medium and act as a polymer backbone for carrying drug, was introduced via a grafting reaction between the amino groups and carboxyl group [107] The results of this research demonstrated that the drug-encapsulated micelles inhibited colorectal cancer stem cells effectively [106] In another research, the amphiphilic doxifluridine-chitosan copolymer was synthesized by grafting a prodrug of 5-fluorouacil (doxifluridine) and hydrophilic chitosan [108] The self-assembled micellar nanoparticles demonstrated the synergistic anticancer activity due to the sustained release of 5-fluorouracil via the slow conversion of doxifluridine   
 
    
 

  
  2.3 Albumin and Other Polymers Recently, albumin (AL) has been another promising material that has drawn a tremendous attention in nanoparticle preparation due to its versatile applications, mild condition preparation and loading capacity of various molecules [109, 110] Moreover, given a wide range of carrier types in drug delivery systems, albumin nanoparticles have been considered as a preferable delivery due to the capability of being easily adaptable to human body [110, 111] A simple and well-known method to produce albumin nanoparticles is coacervation that would be applied in preparation of albumin nanoparticles for targeted colorectal cancer [112, 113] For instance, 5-
urouracil and cetuximab were successfully loaded in albumin nanoparticles and delivered to colon carcinoma cells in some recent reports [101, 114] Briefly, two basic consecutive steps including a desolvation agent addition for phase separation and rigidization of the coating are involved in the coacevation method (Fig 6) In the first step, albumin is dissolved and incubated in a suitable aqueous solution with or without drug Nanoparticles are formed by continuous dropwise of desolvation agent like ethanol under stirring at specific or room temperature In the second step, an aqueous solution of a crosslinking agent, for instance, glutaraldehyde, is added to the above solution to stabilize the resulting nanoparticles Although popular polymers such as PLGA, CS and AL are most commonly used in a number of colorectal cancer therapeutics research, difficulties in the development of polymer-based nanomaterials for biomedical applications still remain, which hinder the contribution of these polymers to the full potential benefit of therapeutic nanoparticles Chemical modification/synthesis is a current strategy that could modulate the particle size, shape or state of these polymer-based systems The synthesis of halloysite-nanocomposite hydrogel was proposed to be more efficient for colon cancer delivery [115] Sodium hyaluronate and poly (hydroxyethyl methacrylate) were chosen as biocompatible and biodegradable materials for hydrogel formation Subsequently, the encapsulation of 5fluorouracil in the halloysite-nanocomposite hydrogel showed the pH-dependent drug release profile Another approach was addressed to utilize the amphiphilic structure facilitating the selfassembly process to form the corresponding nanoparticles [10] It has been demonstrated that these 7-ethyl-10-hydroxy camptothecin micelle formulations were preferentially accumulated in tumors Higher anti-tumor efficacy and longer circulation time of the mi- 
  Fig (5) Illustration of the ionic gelation method [93] chitosan-based nanogels were prepared by mixing CS solution containing drug and tripolyphosphate under constant stirring The designed formulation could be promising for the treatment of colorectal cancer by prolonging and improving local drug concentration 2.2.3 Solvent Emulsi
cation Evaporation Similar to the solvent emulsification evaporation method in preparing PLGA nanoparticles (Section 2,1), an organic solvent was used for emulsification in addition to the aqueous CS solution Commonly AC, dichloromethane [100], or even acetic acid [4] with or without surfactant and stabilizer can be used as the organic phase It has been noted that a high speed mixer emulsifier or a high-speed homogenizer had to be used to emulsify the mixture in a few hours for promoting particle formation Udompornmongkol et al [100] was successful in encapsulating curcumin for targeted human colorectal adenocarcinoma cell line (HT29) and human colon carcinoma cell line (HCT116) using this method Tummala et al [4] also successfully loaded 5-Fluorouracil to CS-based systems for sustained release and localized drug in treatment of colorectal cancer However, enteric-coating of CS nanoparticles should be conducted as discussed in the surface engineering section below 2.2.4 Chitosan-Based Micelles Hydrophobically modified chitosan by grafting or conjugation with hydrophobic groups is an ideal strategy of forming CS nanoparticles for tumor targeting With regards to amphiphilic structure consisting of hydrophobic grafts on hydrophilic backbone, micelle structure in aqueous medium with outer shell of hydrophilic segments via hydrophobic interactions could be obtained through the self-assembly process [9, 102-105] Hydrophobic drugs such as curcumin and paclitaxel hence could be encapsulated in the core of micelles which is hydrophobic Aiming at enhancing solubility and stability of curcumin for improvement of antitumor activity and inhibition of colorectal cancer stem cells, a formulation containing curcumin in stearic acid-g-chitosan oligosaccharide polymeric micelles has recently been developed [106] Stearic acid-g-chitosan oligosaccharide, an amphiphilic polymer that could form micelles    
 Fig (6) Illustration of coacevation method [101]       
        
  Nanoparticulate Drug Delivery to Colorectal Cancer celles were observed as compared to that of a prodrug of 7-ethyl10-hydroxy camptothecin (irinotecan) at an equivalent dose Very recently, Le et al [116] reported that a hydrophilic methoxypoly(ethylene glycol)-b- poly[-(carbamic acid benzyl ester)-
caprolactone-co-amino-
-caprolactone] iblock copolymer was synthesized via ring-opening polymerization This approach was believed to increase accumulation of nanocarriers with prolonged release of 5-fluorouracil in vitro and in vivo THERANOSTICS AND IMAGING AGENTS The use of theranostic polymer-based nanoparticles is not quite new in fabrication of drug delivery systems for biomedical applications In general there are three strategies in detection of colorectal cancers 3.1 Iron oxide Nanoparticles (IONPs) Among the imaging agents used, iron oxide nanoparticles (IONPs) show their promising applications in biomedical nanotechnology [117] IONPs have be incorporated in the PLGA nanoparticles by a proper method with the aims of developing multifunctional nanoparticles for simultaneous targeted drug delivery, molecular imaging and therapeutic response monitoring or the thermosensitivity of colorectal cancer (Fig 7) Generally, IONPs were dispersed in an organic solution with or without PLGA before encapsulation For instance, in the study by Schleich et al [118], PLGA was dissolved in dichloromethane containing IONPs and using emulsion solvent evaporation method for encapsulation of doxorubicin or paclitaxel This research suggested that these nanoparticles with high uptake and magnetic characteristics not only inhibited the CT26 cells growth but also supported the MRI imaging In another research developed by Esmaelbeygi et al [1], dichloromethane was also used to disperse IONPs However, IONPs were encapsulated in PLGA nanoparticles by multiple emulsions–solvent evaporation methods Consequently, this drug delivery system was effective for the treatment of colorectal cancer due to the assistance of harmful hyperthermia   

   
       
  Fig (7) Example of iron oxide-based multifunctional nanoparticles for theranostics of colorectal cancer 3.2 5-Aminolaevulinic Acid 5-aminolaevulinic acid is known as a precursor during heme group synthesis [119] In human body, it is totally degraded in the cells and converted to protoporphyrin IX which is excited by optima light to generate fluorescence in cancer lesions [120, 121] Therefore, 5-aminolaevulinic acid is a promising material in detecting malignant or premalignant tissue [122] Recent articles addressed this issue by encapsulation of 5-aminolaevulinic acid in chitosan nanoparticles showed that these nanoparticles played a significant role in fluorescent endoscopic detection [122-125] Current Pharmaceutical Design, 2016, Vol 22, No 00 3.3 Near-Infrared Fluorescence (NIRF) Imaging Dye Like other imaging agents, NIFR imaging dye is encapsulated in nanoparticles to improve photostability, biocompatibility and fluorescent signal NIRF imaging has multi-detection capability and high sensitivity in cancer imaging and therapy [126] Still, new NIR fluorescence imaging dyes have been developed to observe tumors with the enhanced fluorescent signal (IR-783) [127] The targeting theranostic system using NIRF imaging dye (Cy5.5) and anticancer drug (irinotecan) was also evaluated by Choi et al [128] for therapy and early diagnosis of colorectal cancer SURFACE ENGINEERING With a possibility of surface modification, nanoparticles, therefore, could target and accumulate in a specific tissue [101] Several approaches have been investigated for targeting the colonic cancer region 4.1 Chitosan-Coated Microspheres The most promising process of surface modification in targeted colorectal cancer is the CS coating on surface of PLGA nanoparticles An original PLGA, which has shortage of functional groups on surface, has been suggested to be coated by chitosan for specialized targeting and biomimetic purposes [129] The CS outer shell also facilitated a sustained drug release and an increased stability of macromolecules like proteins, as well as the promotion of cellular adhesion and the retention of the delivery system at the target site [130-132] Generally, CS could be coated on the surface of PLGA nanoparticles by two basic methods so-called physical adsorption and chemical binding [133] (Fig 8) According to the results of this research, pH values of CS solution could be modified to regulate the surface charges of nanoparticles and would benefit more affinity to cancer cells Besides, controlled drug release would be achieved through this system In addition to the coating process of PLGA nanoparticles, chitosan-coated alginate microparticles containing oxaliplatin were investigated for oral administration for colorectal cancer [134] This research proposed that mucoadhesive microspheres, and particularly pH sensitive character could prevent drug release at an acidic environment and deliver the chemotherapeutics to the intestinal site specifically In vivo data demonstrated that efficient therapeutic effects in an orthotopic mouse model of colorectal cancer were observed by substantially reduced the tumor burden and reduced mortality 4.2 Enteric Coating Enteric coating are usually applied for solid dosage forms like tablets and capsules for delayed release formulations [135, 136] In these applications, enteric coating materials should be efficient and safe for controlled drug delivery [137] Various types of aqueous coating suspensions are currently available such as Aquacoat®, Surelease®, Kollicoat®, Eudragit®, Advantia® and Acryl-Eze® with advantages for toxicology and environment [138] For targeting colorectal cancer by polymer-based nanoparticles, Eudragit® S100 is a preferred selection due to its ability of dissolving at pH or higher only [4, 42, 92] Conventional coating pan is generally applied in the coating process [4, 92] or oil-in-oil solvent evaporation method [42] 4.3 Ligand Conjugation Although ligand conjugation has been reported in various types of nanoparticles for targeting purposes [139-141], there have been only a few reports about targeting colon cancer cells using ligand conjugation in polymer-based nanoparticles Folic acid [44, 90] and hyaluronic acid [91, 92] are the most common targeting ligand in recent research Folate receptors are highly expressed in colorectal and numerous tumors [142-144] Consequently, the utility of folic acid in conjugated nanoparticles as a recognition moiety has been Current Pharmaceutical Design, 2016, Vol 22, No 00  
 Tran et al   
 
    Fig (8) Examples of two basic methods of chitosan-coated microspheres [133] investigated extensively due to its ease of conjugation, high affinity for the folate receptor and the limited distribution of its receptor in normal tissues [145, 146] Hyaluronic acid, another ligand conjugation, possesses a high binding affinity to various cancer cells (overexpressed CD44) specifically [147-149] Given excellent properties including nontoxic, nonimmunogenic and particularly versatile modifications, hyaluronic acid-decorated nanoparticles have been extensively investigated in cancer therapy [150-152] CONCLUSION AND FUTURE PERSPECTIVES Recent advances in polymer-based nanoparticles have indicated the potential use of polymers in both therapy and diagnosis of colorectal cancer PLGA and CS are popular polymers which have been most frequently explored Moreover, an increasing number of investigations on albumin or discovery of new materials demonstrates the importance of relevant studies in the field Surface engineering techniques which provide more versatile methods for cell-specific targeting of nanoparticles have been exploited in an effort to reach a successful treatment of the cancer In parallel to studies of optimized drug carriers, research towards imaging agents for diagnosis of precancerous colonic lesions using polymer-based nanoparticles leads to new key tools for theranostics Although in the past most research focused on several carrier types loaded with approved pharmaceutical ingredients for colorectal cancer therapy, an increasing number of studies on smart nano-based systems with new nanomaterials and potential surface engineering for theranostics brings an expectation of important beneficiaries of these inventions in near future ACKNOWLEDEGMENTS We would like to thank Institute for Frontier Materials (Deakin University, Waurn Ponds, Victoria, Australia) and Australian Government for their supports and offering the Endeavour Fellowships program to Dr Thao Truong-Dinh Tran to undertake study, research and professional development in Australia We also thank International University, Vietnam National University – Ho Chi Minh City for their continued, generous supports to our activities CONFLICT OF INTEREST The authors confirm that this article content has no conflict of interest REFERENCES [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Esmaelbeygi E, Khoei S, Khoee S, et al Role of iron oxide core of polymeric nanoparticles in the thermosensitivity of colon cancer cell line HT-29 Int J Hyperthermia 2015; 31: 489-97 Wang C, Zhao M, Liu YR, et al Suppression of colorectal cancer subcutaneous xenograft and experimental lung metastasis using nanoparticle-mediated drug delivery to tumor neovasculature Biomaterials 2014; 35: 1215-26 Hua S, Marks E, Schneider JJ, et al Advances in oral nanodelivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue Nanomedicine 2015; 11: 1117-32 Tummala S, Satish Kumar MN, Prakash A Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer Saudi Pharm J 2015; 23: 308-14 Musumeci T, Ventura CA, Giannone I, et al PLA/PLGA nanoparticles for sustained release of docetaxel Int J Pharm 2006; 325: 172-9 Singla AK, Garg A, Aggarwal D Paclitaxel and its formulations Int J Pharm 2002; 235: 179-92 Tran TT-D, Tran PH-L, Phan M-N, et al Colon specific delivery of fucoidan by incorporation of acidifier in enteric coating polymer Int J Pharm Biosci Technol 2013; 1: 108-17 Tabatabaei Mirakabad FS, Nejati-Koshki K, Akbarzadeh A, et al PLGA-based nanoparticles as cancer drug delivery systems Asian Pac J Cancer Prev 2014; 15: 517-535 Prabaharan M Chitosan-based nanoparticles for tumor-targeted drug delivery Int J Biol Macromol 2015; 72: 1313-22 Xu G, Shi C, Guo D, et al Functional-segregated coumarincontaining telodendrimer nanocarriers for efficient delivery of SN38 for colon cancer treatment Acta Biomater 2015; 21: 85-98 Haggar FA, Boushey RP Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors Clin Colon Rectal Surg 2009; 22: 191-7 Danhier F, Ansorena E, Silva JM, et al PLGA-based nanoparticles: an overview of biomedical applications J Control Release 2012; 161: 505-22 Tran V-T, Bent J-P, Venier-Julienne M-C Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? Int J Pharm 2011; 407: 1-11 Makadia HK, Siegel SJ Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier Polymers 2011; 3: 1377-97 Nanoparticulate Drug Delivery to Colorectal Cancer [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] Choi J-S, Seo K, Yoo J-W Recent advances in PLGA particulate systems for drug delivery J Pharm Investig 2012; 42: 155-63 Thakur VK, Thakur MK Handbook of Polymers for Pharmaceutical Technologies, Processing and Applications USA: John Wiley & Sons 2015 Croll TI, O'Connor AJ, Stevens GW, et al Controllable surface modification of poly (lactic-co-glycolic acid)(PLGA) by hydrolysis or aminolysis I: physical, chemical, and theoretical aspects Biomacromolecules 2004; 5: 463-73 Lü J-M, Wang X, Marin-Muller C, et al Current advances in research and clinical applications of PLGA-based nanotechnology Expert Rev Mol Diagn 2009; 9: 325-41 Chaubal M Polylactides/glycolides-excipients for injectable drug delivery and beyond Drug Deliv Technol 2002; 2: 34-6 Balashanmugam MV, Nagarethinam S, Jagani H, et al Preparation and Characterization of Novel PBAE/PLGA Polymer Blend Microparticles for DNA Vaccine Delivery Scientific World J 2014; 2014: Doiron AL Targetable PLGA microparticles and nanoparticles for the magnetic resonance imaging of atherosclerosis Disseitation The University of Texas 2008 He Z, Wang Q, Sun Y, et al The biocompatibility evaluation of mPEG-PLGA-PLL copolymer and different LA/GA ratio effects for biocompatibility J Biomater Sci Polym Ed 2014; 25: 943-64 Karahalilolu Z, Ercan B, Denkba E, et al Nanostructured 3D PLGA scaffolds for skin-tissue Engineering applications Proceedings of 2013 Annual Meeting, American Institute of Chemical Engineers, November 3-8; San Francisco, CA 2013 Sun Y, Niu C, Zheng Y, et al Laser-activated PLGA theranostic agents for cancer therapy in vivo Proceedings of Ultrasonics Symposium (IUS) 2014 IEEE International IEEE 2014; pp 919-22 Mahato RI, Narang AS Pharmaceutical dosage forms and drug delivery USA: CRC Press 2011 Morales-Cruz M, Flores-Fernández GM, Morales-Cruz M, et al Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres Results Pharm Sci 2012; 2: 79-85 Archana R, Yoshikata N, Yutaka N, et al Hollow polymeric (PLGA) nano capsules synthesized using solvent emulsion evaporation method for enhanced drug encapsulation and release efficiency Mater Res Express 2014; 1: 045407 Wang H, Liu J, Tao S, et al Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system Int J Nanomed 2015; 10: 5671 Gentile P, Chiono V, Carmagnola I, et al An overview of poly (lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering Int J Mol Sci 2014; 15: 3640-59 Wang ZY, Zhao YM, Wang F, et al Syntheses of poly (lactic acid
co
glycolic acid) serial biodegradable polymer materials via direct melt polycondensation and their characterization J Appl Polym Sci 2006; 99: 244-52 Wang X, Lian K, Chen T Experiment research on bonding effect of poly(lactic-co-glycolic acid) device by surface treatment method Int J Polym Sci 2015; 2015: 825287 Wang N, Wu XS, Li C, et al Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: I Synthesis and characterization J Biomater Sci, Polym Ed 2000; 11: 301-18 Xie S, Wang S, Zhu L, et al The effect of glycolic acid monomer ratio on the emulsifying activity of PLGA in preparation of proteinloaded SLN Colloids Surf B Biointerfaces 2009; 74: 358-61 Ansary RH, Awang MB, Rahman MM Biodegradable poly (D, Llactic-co-glycolic acid)-based micro/nanoparticles for sustained release of protein drugs-A review Trop J Pharm Res 2014; 13: 117990 Gu Z Bioinspired and biomimetic polymer systems for drug and gene delivery John Wiley & Sons 2015 Stevanovic M, Uskokovic D Poly (lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins Curr Nanosci 2009; 5: 1-14 López-Santos C, Terriza A, Portoles J, et al Physiological degradation mechanisms of PLGA membrane films under oxygen plasma treatment J Phys Chem C Nanomater Interfaces 2015; 119: 2044652 Kim SR, Ho MJ, Lee E, et al Cationic PLGA/Eudragit RL nanoparticles for increasing retention time in synovial cavity after Current Pharmaceutical Design, 2016, Vol 22, No 00 [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] intra-articular injection in knee joint Int J Nanomed 2015; 10: 5263-71 Kumari A, Yadav SK, Yadav SC Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf B Biointerfaces 2010; 75: 1-18 Wei Z, Wang C, Liu H, et al Facile fabrication of biocompatible PLGA drug-carrying microspheres by O/W pickering emulsions Colloids Surf B Biointerfaces 2012; 91: 97-105 Jaidev LR, Krishnan UM, Sethuraman S Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy Mater Sci Eng C Mater Biol Appl 2015; 47: 40-7 Wang C, Ho PC, Lim LY Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells Int J Pharm 2010; 400: 201-10 Wang Y, Li P, Peng Z, et al Microencapsulation of nanoparticles with enhanced drug loading for pH-sensitive oral drug delivery for the treatment of colon cancer J Appl Polym Sci 2013; 129: 714-20 Wang Y, Li P, Chen L, et al Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles Drug Deliv 2015; 22: 191-8 Ashwanikumar N, Kumar NA, Asha Nair S, et al 5-Fluorouracil– lipid conjugate: Potential candidate for drug delivery through encapsulation in hydrophobic polyester-based nanoparticles Acta Biomater 2014; 10: 4685-4694 Sureban SM, May R, Mondalek FG, et al Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism J Nanobiotechnol 2011; 9: 40 Sengel-Turk CT, Hascicek C, Dogan AL, et al Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT29 human colon adenocarcinoma cells Drug Dev Ind Pharm 2012; 38: 1107-16 Allémann E, Gurny R, Doelker E Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle size Int J Pharm 1992; 87: 24753 Allémann E, Leroux J-C, Gurny R, et al In vitro extended-release properties of drug-loaded poly (DL-lactic acid) nanoparticles produced by a salting-out procedure Pharm Res 1993; 10: 1732-37 Ibrahim H, Bindschaedler C, Doelker E, et al Aqueous nanodispersions prepared by a salting-out process Int J Pharm 1992; 87: 239-46 Galindo-Rodriguez S, Allemann E, Fessi H, et al Physicochemical parameters associated with nanoparticle formation in the saltingout, emulsification-diffusion, and nanoprecipitation methods Pharm Res 2004; 21: 1428-39 Tran TT-D, Tran KA, Tran PH Modulation of particle size and molecular interactions by sonoprecipitation method for enhancing dissolution rate of poorly water-soluble drug Ultrason Sonochem 2015; 24: 256-63 Tran TT-D, Tran PH-L, Nguyen MNU, et al Amorphous isradipine nanosuspension by the sonoprecipitation method Int J Pharm 2014; 474: 146-50 Sah E, Sah H Recent trends in preparation of poly(lactide-coglycolide) nanoparticles by mixing polymeric organic solution with antisolvent J Nanomater 2015; 2015: 22 Dutta PK, Dutta J Multifaceted development and application of biopolymers for biology, biomedicine and nanotechnology USA: Springer 2013 Niwa T, Takeuchi H, Hino T, et al In vitro drug release behavior of D, L
lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method J Pharm Sci 1994; 83: 727-32 Dinarvand R, Sepehri N, Manoochehri S, et al Polylactide-coglycolide nanoparticles for controlled delivery of anticancer agents Int J Nanomedicine 2011; 6: 877-95 Banker GS, Siepmann J, Rhodes C Modern pharmaceutics CRC Press 2002 De A, Bose R, Kumar A, Mozumdar S Targeted delivery of pesticides using biodegradable polymeric nanoparticles USA: Springer 2014 McCarron PA, Donnelly RF, Marouf W Celecoxib-loaded poly (D, L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure J Microencapsul 2006; 23: 48098 8 Current Pharmaceutical Design, 2016, Vol 22, No 00 [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] Zweers ML, Grijpma DW, Engbers GH, et al The preparation of monodisperse biodegradable polyester nanoparticles with a controlled size J Biomed Mater Res B Appl Biomater 2003; 66: 55966 Sah E, Sah H Recent Trends in Preparation of Poly(lactide-coglycolide) Nanoparticles by Mixing Polymeric Organic Solution with Antisolvent J Nanomater 2015; 2015: 1-22 Singh Y, Chaurasia M, Chourasia MK Drug Delivery using Polymeric and other Carrier Systems In: Chourasia MK, Chaurasia M, Jain A, Eds Novel Carriers for Drug Delivery India: PharmaMed Press 2015; pp 1-42 Jung T, Kamm W, Breitenbach A, et al Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm 2000; 50: 147-60 Lambert G, Fattal E, Couvreur P Nanoparticulate systems for the delivery of antisense oligonucleotides Adv Drug Deliv Rev 2001; 47: 99-112 Nagavarma B, Yadav HK, Ayaz A, et al Different techniques for preparation of polymeric nanoparticles—a review Asian J Pharm Clin Res 2012; 5: 16-23 Barichello JM, Morishita M, Takayama K, et al Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug Dev Ind Pharm 1999; 25: 471-76 Shinde AJ, More HN Formulation, development and characterization of Simvastatin nanoparticles by solvent displacement method Der Pharm Lett 2014; 6: 145-55 Mitra A, Lee CH, Cheng K Advanced Drug Delivery USA: John Wiley & Sons 2013 Li L, Xiang D, Shigdar S, et al Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells Int J Nanomed 2014; 9: 1083 Lueßen HL, de Leeuw BJ, Langemeÿer MW, et al Mucoadhesive polymers in peroral peptide drug delivery VI Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo Pharm Res 1996; 13: 1668-72 Shin GH, Chung SK, Kim JT, et al Preparation of chitosan-coated nanoliposomes for improving the mucoadhesive property of curcumin using the ethanol injection method J Agric Food Chem 2013; 61: 11119-26 Du H, Liu M, Yang X, et al The design of pH-sensitive chitosanbased formulations for gastrointestinal delivery Drug Discov Today 2015; 20: 1004-11 Sakloetsakun D, Perera G, Hombach J, et al The impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: a case study with chitosan-4-thiobutylamidine conjugate AAPS PharmSciTech 2010; 11: 1185-92 Sezer AD, Cevher E Topical drug delivery using chitosan nanoand microparticles Expert Opin Drug Deliv 2012; 9: 1129-46 Kim K, Kim K, Ryu JH, et al Chitosan-catechol: A polymer with long-lasting mucoadhesive properties Biomaterials 2015; 52: 16170 Porporatto C, Canali MM, Bianco ID, et al The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen Clin Exp Immunol 2009; 155: 79-87 Caban S, Capan Y, Couvreur P, et al Preparation and Characterization of Biocompatible Chitosan Nanoparticles for Targeted Brain Delivery of Peptides In: Skaper SD, eds Neurotrophic Factors USA: Humana Press 2012; pp 321-332 Zhang H, Mardyani S, Chan WCW, et al Design of Biocompatible Chitosan Microgels for Targeted pH-Mediated Intracellular Release of Cancer Therapeutics Biomacromolecules 2006; 7: 1568-72 Tan WB, Huang N, Zhang Y Ultrafine biocompatible chitosan nanoparticles encapsulating multi-coloured quantum dots for bioapplications J Colloid Interface Sci 2007; 310: 464-70 Mao C, Imtiaz SA, Zhang Y Competitive adsorption of Ag (I) and Cu (II) by tripolyphosphate crosslinked chitosan beads J Appl Polym Sci 2015: 132: 42717 Takei T, Nakahara H, Ijima H, et al Synthesis of a chitosan derivative soluble at neutral pH and gellable by freeze–thawing, and its application in wound care Acta Biomater 2012; 8: 686-93 Pahwa R, Saini N, Kumar V, et al Chitosan-based gastroretentive floating drug delivery technology: an updated review Expert Opin Drug Deliv 2012; 9: 525-39 Kim S-K Chitin and chitosan derivatives: Advances in drug discovery and developments USA: CRC Press 2013 Tran et al [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] Kumirska J, Weinhold MX, Czerwicka M, et al Influence of the chemical structure and physicochemical properties of chitin-and chitosan-based materials on their biomedical activity In Laskovski AN, Eds Biomedical Engineering, Trends Mater Sci 2011: pp 2564 Prokop A Intracellular delivery: fundamentals and applications USA: Springer Science & Business Media 2011 Mattu C, Li R, Ciardelli G Chitosan nanoparticles as therapeutic protein nanocarriers: The effect of ph on particle formation and encapsulation efficiency Polym Composite 2013; 34: 1538-45 Mitra A, Dey B Chitosan microspheres in novel drug delivery systems Indian J Pharm Sci 2011; 73: 355-66 Guo C Chitosan-coated Poly (lactide-co-glycolide) Nanoparticles for DNA Delivery Dissertations and Theses ProQuest 2007 Li P, Wang Y, Zeng F, et al Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells Carbohydr Res 2011; 346: 801-6 Jain A, Jain SK In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors Eur J Pharm Sci 2008; 35: 404-16 Jain A, Jain SK, Ganesh N, et al Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer Nanomedicine 2010; 6: 179-90 Li P, Wang Y, Peng Z, et al Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends Carbohydr Polym 2011; 85: 698-704 Xu Q, Guo L, Gu X, et al Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosanTPP/nanoparticles formulated with IL-12 Biomaterials 2012; 33: 3909-18 Lin Y-H, Chung C-K, Chen C-T, et al Preparation of nanoparticles composed of chitosan/poly-
-glutamic acid and evaluation of their permeability through Caco-2 cells Biomacromolecules 2005; 6: 1104-12 Prakash S Artificial cells, cell engineering and therapy UK: Elsevier 2007 Chu PK, Liu X Biomaterials fabrication and processing handbook USA: CRC press 2008 Feng C, Sun G, Wang Z, et al Transport mechanism of doxorubicin loaded chitosan based nanogels across intestinal epithelium Eur J Pharm Biopharm 2014; 87: 197-207 Feng C, Li J, Kong M, et al Surface charge effect on mucoadhesion of chitosan based nanogels for local anti-colorectal cancer drug delivery Colloids Surf B Biointerfaces 2015; 128: 439-47 Udompornmongkol P, Chiang B-H Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications J Biomater appl 2015; 30: 537-46 Tran PH-L, Tran TT-D, Vo TV Polymer conjugate-based nanomaterials for drug delivery J Nanosci Nanotechnol 2014; 14: 815-27 Tran PH-L, Tran TT-D, Vo TV, et al Novel multifunctional biocompatible gelatin-oleic acid conjugate: self-assembled nanoparticles for drug delivery J Biomed Nanotechnol 2013; 9: 1416-31 Tran PH-L, Tran TT-D, Lee B-J Biodistribution and pharmacokinetics in rats and antitumor effect in various types of tumor-bearing mice of novel self-assembled gelatin-oleic acid nanoparticles containing paclitaxel J Biomed Nanotechnol 2014; 10: 154-65 Tran PH-L, Tran TT-D, Lee B-J Enhanced solubility and modified release of poorly water-soluble drugs via self-assembled gelatin– oleic acid nanoparticles Int J Pharm 2013; 455: 235-40 Wang K, Zhang T, Liu L, et al Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells Int J Nanomed 2012; 7: 4487-97 Hu F-Q, Liu L-N, Du Y-Z, et al Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles Biomaterials 2009; 30: 6955-63 Wang J, Peng CA Anticancer effectiveness of polymeric drug nanocarriers on colorectal cancer cells Conf Proc IEEE Eng Med Biol Soc 2011; 2011: 3249-52 Karimi M, Avci P, Mobasseri R, et al The novel albumin-chitosan core-shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation J Nanopart Res 2013; 15: 1651 Tran TT-D, Vo TV, Tran PH-L Design of iron oxide nanoparticles decorated oleic acid and bovine serum albumin for drug delivery Chem Eng Res De 2015; 94: 112-8 Nanoparticulate Drug Delivery to Colorectal Cancer [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] Rahimnejad M, Jahanshahi M, Najafpour GD Production of biological nanoparticles from bovine serum albumin for drug delivery Afr J Biotechnol 2006; 5: 1918-23 Lazko J, Popineau Y, Legrand J Soy glycinin microcapsules by simple coacervation method Colloids Surf B Biointerfaces 2004; 37: 1-8 Rahimnejad M, Jahanshahi M, Najafpour G Production of biological nanoparticles from bovine serum albumin for drug delivery Afr J Biotechnol 2010; 1918-23 Wilson B, Ambika TV, Patel RD, et al, Priyadarshini SR Nanoparticles based on albumin: preparation, characterization and the use for 5-flurouracil delivery Int J Biol Macromol 2012; 51: 874-8 Low K, Wacker M, Wagner S, et al Targeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cells Nanomedicine 2011; 7: 454-63 Rao KM, Nagappan S, Seo DJ, et al pH sensitive halloysitesodium hyaluronate/poly(hydroxyethyl methacrylate) nanocomposites for colon cancer drug delivery Appl Clay Sci 2014; 97-98: 33-42 Le V-M, Wang J-J, Yuan M, et al An investigation of antitumor efficiency of novel sustained and targeted 5-fluorouracil nanoparticles Eur J Med Chem 2015; 92: 882-9 Tran PH, Tran TT, Vo TV, et al Promising iron oxide-based magnetic nanoparticles in biomedical engineering Arch Pharm Res 2012; 35: 2045-61 Schleich N, Sibret P, Danhier P, et al Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging Int J Pharm 2013; 447: 94-101 Wesselinova D Current major cancer targets for nanoparticle systems Curr Cancer Drug Targets 2011; 11: 164-83 Allison RR, Cuenca R, Downie GH, et al PD/PDT for gynecological disease: A clinical review Photodiagnosis Photodyn Ther 2005; 2: 51-63 Yang SJ, Lin FH, Tsai HM, et al Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms Biomaterials 2011; 32: 2174-82 Yang S-J, Lin F-H, Tsai K-C, et al Folic Acid-Conjugated Chitosan Nanoparticles Enhanced Protoporphyrin IX Accumulation in Colorectal Cancer Cells Bioconjug Chem 2010; 21: 679-89 Yang S, Lin F, Tsai K, et al A Novel Detection of Early Colorectal Cancer by Chitosan Nanoparticles Conjugated with Folic Acid Technical Proceedings of the 2007 NSTI Nanotechnology Conference and Trade Show NSTI-Nanotech 2007; 4: 242-5 Yang SJ, Shieh MJ, Lin FH, et al Colorectal cancer cell detection by 5-aminolaevulinic acid-loaded chitosan nano-particles Cancer Lett 2009; 273: 210-20 Jayakumar R, Muzzarelli R, Prabaharan M Chitosan for Biomaterials I Preface Berlin Heidelberger: Springer-Verlag 2011 Yi X, Wang F, Qin W, et al Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field Int J Nanomed 2014; 9: 1347-65 Cohen S, Pellach M, Kam Y, et al Synthesis and characterization of near IR fluorescent albumin nanoparticles for optical detection of colon cancer Mater Sci Eng C Mater Biol Appl 2013; 33: 92331 Choi KY, Jeon EJ, Yoon HY, et al Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer Biomaterials 2012; 33: 6186-93 Fischer S, Foerg C, Merkle HP, et al Chitosan coated plgamicrospheres - a modular system for targeted drug delivery Eur Cells Mater 2004; 7: 11-2 Chronopoulou L, Massimi M, Giardi MF, et al Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures Colloids Surf B Biointerfaces 2013; 103: 310-7 Budhian A, Siegel SJ, Winey KI Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles Int J Pharm 2008; 346: 151-9 Received: January 4, 2016 Current Pharmaceutical Design, 2016, Vol 22, No 00 [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] Zheng C-H, Gao J-Q, Zhang Y-P, et al A protein delivery system: biodegradable alginate–chitosan–poly(lactic-co-glycolic acid) composite microspheres Biochem Biophys Res Commun 2004; 323: 1321-7 Wang Y, Li P, Kong L Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery AAPS PharmSciTech 2013; 14: 585-92 Urbanska AM, Karagiannis ED, Guajardo G, et al Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer Biomaterials 2012; 33: 4752-61 Doroyski P, Jamróz W, Niwiski K, et al Novel method for screening of enteric film coatings properties with magnetic resonance imaging Int J Pharm 2013; 456: 569-71 Macchi E, Zema L, Maroni A, et al Enteric-coating of pulsatilerelease HPC capsules prepared by injection molding Eur J Pharm Sci 2015; 70: 1-11 Sivapragasam N, Thavarajah P, Ohm J-B, et al Surface properties of semi-synthetic enteric coating films: Opportunities to develop bio-based enteric coating films for colon-targeted delivery Bioact Carbohydr Diet Fibre 2014; 4: 139-43 Albanez R, Nitz M, Taranto OP Influence of the type of enteric coating suspension, coating layer and process conditions on dissolution profile and stability of coated pellets of diclofenac sodium Powder Technol 2015; 269: 185-92 Arruebo M, Valladares M, González-Fernández Á Antibodyconjugated nanoparticles for biomedical applications J Nanomater 2009; 2009: 24 Karra N, Benita S The ligand nanoparticle conjugation approach for targeted cancer therapy Curr Drug Metab 2012; 13: 22-41 Friedman AD, Claypool SE, Liu R The smart targeting of nanoparticles Curr Pharm Des 2013; 19: 6315-29 Zwicke GL, Mansoori GA, Jeffery CJ Utilizing the folate receptor for active targeting of cancer nanotherapeutics Nano Rev 2012; 3: 10.3402/nano.v3i0.18496 Parker N, Turk MJ, Westrick E, et al Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay Anal Biochem 2005; 338: 284-93 Garin-Chesa P, Campbell I, Saigo P, et al Trophoblast and ovarian cancer antigen LK26 Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein Am J Pathol 1993; 142: 557 Cal PMSD, Frade RFM, Chudasama V, et al Targeting cancer cells with folic acid-iminoboronate fluorescent conjugates Chem Commun 2014; 50: 5261-3 Low PS, Henne WA, Doorneweerd DD Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases Acc Chem Res 2008; 41: 120-9 Choi KY, Chung H, Min KH, et al Self-assembled hyaluronic acid nanoparticles for active tumor targeting Biomaterials 2010; 31: 106-14 Ossipov DA Nanostructured hyaluronic acid-based materials for active delivery to cancer Expert Opin Drug Deliv 2010; 7: 681703 De Santis S, Diociaiuti M, Cametti C, et al Hyaluronic acid and alginate covalent nanogels by template cross-linking in polyion complex micelle nanoreactors Carbohydr Polym 2014; 101: 96103 Lokeshwar VB, Mirza S, Jordan A Targeting Hyaluronic Acid Family for Cancer Chemoprevention and Therapy In: Melanie AS, Paraskevi H, Eds Advances in Cancer Research USA: Academic Press 2014; pp 35-65 Almeida PV, Shahbazi M-A, Makila E, et al Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors Nanoscale 2014; 6: 10377-87 Yadav AK, Mishra P, Agrawal GP An insight on hyaluronic acid in drug targeting and drug delivery J Drug Target 2008; 16: 91107 Accepted: February 16, 2016 The author has requested enhancement of the downloaded file All in-text references underlined in blue are linked to publications on ResearchGate  ... MgCl2, magnesium acetate, NaCl Nanoparticulate Drug Delivery to Colorectal Cancer Current Pharmaceutical Design, 2016, Vol 22, No 00 Probe sonicator Probe sonicator Drug PVA solution Fig (3) Illustration...     
  Nanoparticulate Drug Delivery to Colorectal Cancer celles were observed as compared to that of a prodrug of 7-ethyl10-hydroxy camptothecin (irinotecan) at an equivalent... range within stomach due to the protonation of amino groups [81-83] CS, therefore, usually needs a modification or nanoparticulate formulation in targeting oral delivery for colorectal cancer in